Imexpharm Corp (IMP) — Cash Flow Reinvestment Rate
Imexpharm Corp (IMP) has a Cash Flow Reinvestment Rate of 0.30x as of June 2026, reinvesting ₫16.90 Billion (capex ₫16.90 Billion ) from operating cash flow of ₫55.75 Billion. See cash generation quality of Imexpharm Corp to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Imexpharm Corp Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Imexpharm Corp across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Imexpharm Corp.
Annual Cash Flow Reinvestment Rate for Imexpharm Corp (2019–2025)
Year-by-year capital reinvestment analysis for Imexpharm Corp. See IMP FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.50x | ₫26.88 Billion | ₫54.17 Billion | ₫26.88 Billion | ▼ -52.1% |
| 2024 | 1.04x | ₫223.97 Billion | ₫216.27 Billion | ₫96.77 Billion | ▲ +31.3% |
| 2022 | 0.79x | ₫298.66 Billion | ₫378.60 Billion | ₫99.35 Billion | ▼ -37.8% |
| 2021 | 1.27x | ₫297.80 Billion | ₫234.88 Billion | ₫52.86 Billion | ▼ -52.6% |
| 2020 | 2.67x | ₫195.62 Billion | ₫73.15 Billion | ₫89.68 Billion | ▲ +9.1% |
| 2019 | 2.45x | ₫163.21 Billion | ₫66.59 Billion | ₫131.12 Billion | — |